Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesSuccessful Treatment of Infected Residual Pleural Space After Pulmonary Resection With Autologous Platelet-Leukocyte Gel
Annals of Thoracic Surgery, 11/09/09
De Giacomo T et al. – Complications of the residual pleural space after pulmonary resection have been reported to be between 5% and 40% depending on the type of resection, and they increase morbidity, mortality, hospital stays, and costs. The therapeutic use of autologous prepared platelet leukocyte–enriched gel is a relatively new technology for the stimulation and acceleration of soft tissue and bone healing. This gel can be applied to a diversity of tissue. The authors describe the case of a successful application through a chest tube of platelet leukocyte gel to treat an infected residual pleural space that developed after pulmonary lobectomy for lung cancer.
Today in Surgery/Trauma...keeping you current
Receive free subspecialty "5-minute updates" via email
Pulmonary Embolism and Deep Venous Thrombosis in Trauma
Archives of Surgery, 10/20/09
Pneumonectomy After Neoadjuvant Chemotherapy and Radiation for Advanced-Stage Lung Cancer
Annals of Surgical Oncology, 11/18/09
Postoperative Pulmonary Complications after Laparotomy
Respiration, 10/28/09
Sponsor
Article Search
Sponsor